Abstract
Sleep misperception, whether severe enough to qualify as paradoxical insomnia or not, is common in a number of neurological and psychiatric conditions. The objective was to assess sleep perception in a group of multiple sclerosis (MS) patients. As part of an Institutional Review Board (IRB) approved trial designed to assess the efficacy of eszopiclone versus placebo in improving MS patients' sleep continuity, we observed a pattern of both paradoxical and reverse paradoxical insomnia in a small number of participants. Eight participants (26.7%) had some degree of misperception at some point during the study. Six (20%) had reverse paradoxical insomnia and two (6.7%) had paradoxical insomnia. This is a preliminary observation that we hope will increase awareness of the condition of misperception of sleep in subjects with MS.
Original language | English (US) |
---|---|
Pages (from-to) | 124-126 |
Number of pages | 3 |
Journal | Clinical and Experimental Neuroimmunology |
Volume | 1 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2010 |
Keywords
- Actigraphyl
- Multiple sclerosis
- Paradoxical insomnia
- Reverse paradoxical insomnia
- Sleep misperception
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Immunology
- Immunology and Microbiology (miscellaneous)
- Clinical Neurology